Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes
- PMID: 10334211
- DOI: 10.1093/carcin/20.5.911
Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes
Abstract
A series of naturally occurring as well as synthetic structural analogs of the dietary constituent curcumin were examined in order to elucidate which portions of the molecule are critical for the ability to induce Phase 2 detoxification enzymes in murine hepatoma cells, and hence to assess the chemoprotective potential of these compounds. Two groups of compounds were studied: classical Michael reaction acceptors such as curcumin and related beta-diketones such as dibenzoylmethane which lack direct Michael reactivity. The presence of two structural elements was found to be required for high inducer potency: (i) hydroxyl groups at ortho-position on the aromatic rings and (ii) the beta-diketone functionality. All curcuminoids elevate the specific activity of quinone reductase in both wild type and mutant cells defective in either the aryl hydrocarbon (Ah) receptor or cytochrome P4501A1 activity. This indicates that neither binding to this receptor, nor metabolic activation by P4501A1 are required for the signaling process originating from this family of electrophiles and ultimately resulting in Phase 2 enzyme induction.
Similar articles
-
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.J Med Chem. 1998 Dec 17;41(26):5287-96. doi: 10.1021/jm980424s. J Med Chem. 1998. PMID: 9857096
-
Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.Cancer Res. 1988 Sep 1;48(17):4776-82. Cancer Res. 1988. PMID: 3409219
-
Mechanisms of induction of enzymes that protect against chemical carcinogenesis.Adv Enzyme Regul. 1989;28:237-50. doi: 10.1016/0065-2571(89)90074-5. Adv Enzyme Regul. 1989. PMID: 2696344 Review.
-
Curcumin and its derivatives inhibit 2,3,7,8,-tetrachloro-dibenzo-p-dioxin-induced expression of drug metabolizing enzymes through aryl hydrocarbon receptor-mediated pathway.Biosci Biotechnol Biochem. 2018 Apr;82(4):616-628. doi: 10.1080/09168451.2017.1386086. Epub 2017 Dec 1. Biosci Biotechnol Biochem. 2018. PMID: 29191105
-
Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogens.Princess Takamatsu Symp. 1990;21:177-87. Princess Takamatsu Symp. 1990. PMID: 2134677 Review.
Cited by
-
The Role of NRF2 in Trinucleotide Repeat Expansion Disorders.Antioxidants (Basel). 2024 May 26;13(6):649. doi: 10.3390/antiox13060649. Antioxidants (Basel). 2024. PMID: 38929088 Free PMC article. Review.
-
TrxR1 as a potent regulator of the Nrf2-Keap1 response system.Antioxid Redox Signal. 2015 Oct 1;23(10):823-53. doi: 10.1089/ars.2015.6378. Epub 2015 Jun 24. Antioxid Redox Signal. 2015. PMID: 26058897 Free PMC article. Review.
-
An internal ribosomal entry site mediates redox-sensitive translation of Nrf2.Nucleic Acids Res. 2010 Jan;38(3):778-88. doi: 10.1093/nar/gkp1048. Epub 2009 Nov 24. Nucleic Acids Res. 2010. PMID: 19934254 Free PMC article.
-
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.Mol Neurobiol. 2011 Oct;44(2):192-201. doi: 10.1007/s12035-011-8181-5. Epub 2011 Apr 19. Mol Neurobiol. 2011. PMID: 21499987 Free PMC article. Review.
-
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.Blood. 2009 Jan 8;113(2):462-9. doi: 10.1182/blood-2008-05-155952. Epub 2008 Sep 24. Blood. 2009. PMID: 18815282 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources